+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID06663306

Phase 1 Study of Pemetrexed and Bevacizumab Intrathecal Injection for Treating Leptomeningeal Metastases in Non-Small Cell Lung Cancer

Led by Shanghai Chest Hospital · Updated on 2026-03-02

19

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of combining two drugs, pemetrexed and bevacizumab, delivered directly into the spinal fluid for patients with leptomeningeal metastases caused by non-small cell lung cancer NSCLC. This phase Ia clinical study aims to gather early data on how well this treatment works and its safety in this specific group of cancer patients who have limited options due to cancer spread in the brain and spinal cord membranes. Participants receive intrathecal injections of pemetrexed twice a week for one week, then once every four weeks. Bevacizumab is given once during the first week with gradually increasing doses, then once every four weeks afterward. The study has two treatment groups one receiving pemetrexed alone and the other receiving both pemetrexed and bevacizumab. This approach allows researchers to compare the combination treatment with pemetrexed alone. During the study, patients will be monitored for side effects and treatment safety from the start of treatment until two months after. Researchers will also track overall survival for up to two years. Participants will undergo regular evaluations including clinical assessments, laboratory tests, and imaging as needed. The total duration and follow-up depend on individual patient progress, with safety and effectiveness carefully observed throughout the study period.

CONDITIONS

Brief Title

Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC

Research Team

H

Hua Zhong, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here